- [Home](https://www.biopharmcatalyst.com/)
- [Catalyst Calendars/\
Catalyst Calendars...](https://www.biopharmcatalyst.com/calendars)
- FDA Calendar/
FDA Calendar

PORTFOLIO MANAGEMENT:

Add New Portfolio

ADD

Our **FDA Calendar** is designed to provide you with future catalysts across biotech & pharma companies, updated on a daily basis for all companies we cover. Utilize our **filter functionality** at the top of the page to screen for companies based on whatever criteria you are looking for or to see your portfolio, and also add more columns to get the most information about these catalysts (scroll to the right to see added columns). Here, you can also add “ **Bullish or Bearish**” and “ **Price Target**” in order to input your own view on a given catalyst, as well as see other community votes!

[iframe](https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-2998754655820592&output=html&h=130&slotname=2901024062&adk=1375090745&adf=3544856738&pi=t.ma~as.2901024062&w=500&abgtt=3&lmt=1719932723&rafmt=11&format=500x130&url=https%3A%2F%2Fwww.biopharmcatalyst.com%2Fcalendars%2Ffda-calendar&wgl=1&uach=WyJXaW5kb3dzIiwiMTAuMC4wIiwieDg2IiwiIiwiMTI0LjAuNjM2Ny43OCIsbnVsbCwwLG51bGwsIjY0IixbWyJDaHJvbWl1bSIsIjEyNC4wLjYzNjcuNzgiXSxbIkdvb2dsZSBDaHJvbWUiLCIxMjQuMC42MzY3Ljc4Il0sWyJOb3QtQS5CcmFuZCIsIjk5LjAuMC4wIl1dLDBd&dt=1719932722310&bpp=18&bdt=2525&idt=865&shv=r20240625&mjsv=m202406250101&ptt=9&saldr=aa&abxe=1&cookie_enabled=1&eoidce=1&correlator=1311049464380&frm=20&pv=2&ga_vid=1178398218.1719932721&ga_sid=1719932723&ga_hid=301851603&ga_fc=1&u_tz=-420&u_his=2&u_h=1080&u_w=1920&u_ah=1080&u_aw=1920&u_cd=16&u_sd=1&dmc=0.001953125&adx=8&ady=1842&biw=1919&bih=992&scr_x=0&scr_y=0&eid=44759837%2C42531705%2C42532523%2C44795921%2C95331689%2C95334509%2C95334524%2C95334571%2C95334830%2C95335888%2C95335247&oid=2&pvsid=1594648592966589&tmod=434270934&uas=3&nvt=1&ref=https%3A%2F%2Fwww.google.com%2F&fc=896&brdim=0%2C0%2C0%2C0%2C1920%2C0%2C1919%2C1079%2C1919%2C992&vis=1&rsz=%7C%7CoeEbr%7C&abl=CS&pfx=0&fu=1152&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=1&uci=a!1&btvi=1&fsb=1&dtd=917)

[Clear](javascript:;)

Showing
10
Catalysts

[SCREENER](https://www.biopharmcatalyst.com/calendars/fda-calendar)

# Upgrade Your Account

- 7 Day Free Trial
- Access Hundreds of Catalysts
- Access Additional Calendars
- Detailed Financials
- Push & Email Notifications
- Track Your Portfolio

[Compare Subscription Plans Here](https://www.biopharmcatalyst.com/sign-up?modal=1)

[Sign Up for Our Most Popular Elite Plan](https://www.biopharmcatalyst.com/sign-up?modal=1)

Subscriptions have [Terms & Conditions](https://www.biopharmcatalyst.com/terms-of-use) including but not limited to limited time discounts, trial periods, and lock in clauses. No money charged until free trial is up.

[Already signed up? Login here](https://www.biopharmcatalyst.com/account/login)

| Ticker | Name | Price % $ | 30 Day Price Change | Drug | NCT Number | Indication | Stage | Status | Options | Next Catalyst | Catalyst Date | Catalyst | Conference | Historical LOA | Historical POP | Bullish or Bearish | Last Updated |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [KZIA](https://www.biopharmcatalyst.com/company/KZIA) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/KZIA/round.png) Kazia Therapeutics Limited | $0.23 +0.01 +3.78% | | **Paxalisib (PNOC022)** [View Clinical Trial Data](javascript:;) | [NCT05009992](https://clinicaltrials.gov/study/NCT05009992) | Diffuse intrinsic pontine glioma (DIPG) and diffuse midline gliomas (DMGs). | Phase 2 | Ongoing | View | Conference Presentation | [07/02/2024 ET](https://www.biopharmcatalyst.com/company/KZIA/news/213124) | Phase 2 study to be discussed at the 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) on July 2, 2024. Phase 2 study initiated, noted November 10, 2021. Phase 2 data shared at th [… read more](javascript:;) | | 100 | 100 | Vote | 06/27/2024 ET |
| [ARQT](https://www.biopharmcatalyst.com/company/ARQT) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/ARQT/round.png) Arcutis Biotherapeutics Inc. | $9.30 -0.27 -2.77% | | **Roflumilast Cream (ARQ-151) - (INTEGUMENT-1 and INTEGUMENT-2)** | | Atopic dermatitis | PDUFA | Ongoing | View | Regulatory Decision | [07/07/2024 ET](https://biopharmcatalyst.com/company/ARQT/news/204062) | PDUFA Date on July 7, 2024. | | 100 | 100 | Vote | 05/15/2024 ET |
| [BCLI](https://www.biopharmcatalyst.com/company/BCLI) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/BCLI/round.png) Brainstorm Cell Therapeutics Inc. | $0.35 -0.01 -1.89% | | **NurOwn** [View Clinical Trial Data](javascript:;) | [NCT03280056](https://clinicaltrials.gov/study/NCT03280056) | Amytrophic lateral sclerosis (ALS) | Phase 3 | Trial Planned | View | | [07/08/2024 ET](https://www.biopharmcatalyst.com/company/BCLI/news/213563) | Program update due on July 8, 2024. Phase 3b trial to commence in 2024. SPA agreement reached with the FDA noted April 9, 2024. Meeting with the FDA on December 6, 2023. Advisory Committee meeting vot [… read more](javascript:;) | | 100 | 100 | Vote | 07/01/2024 ET |
| [HCM](https://www.biopharmcatalyst.com/company/HCM) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/HCM/round.png) HUTCHMED (China) Limited | $17.25 -0.31 -1.77% | | **SULANDA (surufatinib)** | [NCT06361888](https://clinicaltrials.gov/study/NCT06361888) | Metastatic pancreatic ductal adenocarcinoma ("PDAC") in China | Phase 2/3 | Enrollment Initiation | View | Conference Presentation | [07/09/2024 ET](https://www.biopharmcatalyst.com/company/HCM/news/212248) | Phase 2/3 study initiated in China, noted May 14, 2024. Phase 2/3 data update expected at R&D webcast on July 9, 2024. | | 100 | 100 | Vote | 06/24/2024 ET |
| [HCM](https://www.biopharmcatalyst.com/company/HCM) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/HCM/round.png) HUTCHMED (China) Limited | $17.25 -0.31 -1.77% | | **HMPL-523 - (ESLIM-01)** BTD | [NCT03951623](https://clinicaltrials.gov/study/NCT03951623) | Primary immune thrombocytopenia (ITP) | Phase 3 | Data Released | View | Conference Presentation | [07/09/2024 ET](https://www.biopharmcatalyst.com/company/HCM/news/212248) | Phase 3 data update expected at R&D webcast on July 9, 2024. Phase 3 data presented at EHA reported a durable response rate of 48.4% vs. 0% with placebo, noted June 14, 2024. Phase 3 trial met is prim [… read more](javascript:;) | | 100 | 100 | Vote | 06/24/2024 ET |
| [HCM](https://www.biopharmcatalyst.com/company/HCM) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/HCM/round.png) HUTCHMED (China) Limited | $17.25 -0.31 -1.77% | | **Sovleplenib - (ESLIM-02)** | [NCT05535933](https://clinicaltrials.gov/study/NCT05535933) | Warm antibody autoimmune hemolytic anemia (wAIHA) | Phase 2/3 | Enrollment Initiation | View | Conference Presentation | [07/09/2024 ET](https://www.biopharmcatalyst.com/company/HCM/news/212248) | Phase 2/3 data update expected at R&D webcast on July 9, 2024. Phase 2 data presented at EHA on June 16, 2024. Phase 2/3 trial initiated March 22, 2024. | | 100 | 100 | Vote | 06/24/2024 ET |
| [HCM](https://www.biopharmcatalyst.com/company/HCM) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/HCM/round.png) HUTCHMED (China) Limited | $17.25 -0.31 -1.77% | | **HMPL-306 - (RAPHAEL)** | [NCT06387069](https://clinicaltrials.gov/study/NCT06387069) | Relapsed / refractory acute myeloid leukemia (AML) | Phase 3 | Ongoing | View | Conference Presentation | [07/09/2024 ET](https://www.biopharmcatalyst.com/company/HCM/news/212248) | Phase 3 data update expected at R&D webcast on July 9, 2024. Phase 1 data reported that the best of response was 1CR in 100 mg cohort; 9 CRs and 1 PR in 150 mg QD; 1 CR in 200 mg QD; and 3 CRs in 250 [… read more](javascript:;) | | 100 | 100 | Vote | 06/24/2024 ET |
| [MESO](https://www.biopharmcatalyst.com/company/MESO) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/MESO/round.png) Mesoblast Limited | $6.37 -0.41 -6.05% | | **RYONCIL (remestemcel-L) - (MSB-GVHD001)** | [NCT02336230](https://clinicaltrials.gov/study/NCT02336230) | Pediatric participants with acute graft versus host disease (aGVHD), following allogeneic hematopoietic stem cell transplant (HSCT) | BLA Filing | Type Meeting | View | Submission | [07/12/2024 ET](https://www.biopharmcatalyst.com/company/MESO/news/213541) | BLA resubmission due the week of July 12, 2024. Type A meeting noted the lack of a suitable potency assay for the RYONCIL product used during the Phase 3 trial, new potency assay data to be generated, [… read more](javascript:;) | | 100 | 100 | Vote | 07/01/2024 ET |
| [NVCR](https://www.biopharmcatalyst.com/company/NVCR) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/NVCR/round.png) NovoCure Limited | $17.26 -0.09 -0.52% | | **Tumor Treating Fields (TTFields) - (LUNAR)** [View Clinical Trial Data](javascript:;) | [NCT02973789](https://clinicaltrials.gov/study/NCT02973789) | Non-small cell lung cancer (NSCLC) | Phase 3 | Data Released | View | Conference Presentation | [07/17/2024 ET](https://www.biopharmcatalyst.com/company/ADVM/news/199518) | Additional Phase 3 readout by year-end 2024. Phase 3 study met its primary endpoint, noted January 5, 2023. Additional Phase 3 data to be shared at ASRS on July 17, 2024. | | 100 | 100 | Vote | 06/04/2024 ET |
| [ZLAB](https://www.biopharmcatalyst.com/company/ZLAB) Add to portfolio | ![](https://www.biopharmcatalyst.com/logos/ZLAB/round.png) Zai Lab Limited | $17.10 -0.19 -1.10% | | **Tumor Treating Fields (TTFields) - (LUNAR)** [View Clinical Trial Data](javascript:;) | [NCT02973789](https://clinicaltrials.gov/study/NCT02973789) | Non-small cell lung cancer (NSCLC) | Phase 3 | Data Released | View | Conference Presentation | [07/17/2024 ET](https://www.biopharmcatalyst.com/company/ADVM/news/199518) | Additional Phase 3 readout by year-end 2024. Phase 3 study met its primary endpoint, noted January 5, 2023. Additional Phase 3 data to be shared at ASRS on July 17, 2024. | | 100 | 100 | Vote | 06/04/2024 ET |

# Please Answer Your User Profile Questions

How did you hear about us? \*

p-emptylabel

Are you using BPC for business or personal use? \*

p-emptylabel

How many years of of trading/investing experience do
you have? \*

p-emptylabel

What therapeutic areas are you most interested in?
\*

empty

What modalities are you most interested in?
\*

empty

Submit

##### \*Why We Are Asking

As we work to create exciting new content, including interviews,
webinars, and articles,
we are aiming to get a better understanding of our user base so that
we can guide these advances in the right
direction. Per our privacy policy, we will never sell or redistribute
your information to third parties.

# Upgrade Your Account

- 7 Day Free Trial
- Access Hundreds of Catalysts
- Access Additional Calendars
- Detailed Financials
- Push & Email Notifications
- Track Your Portfolio

[Compare Subscription Plans Here](https://www.biopharmcatalyst.com/sign-up?modal=1)

[Sign Up for Our Most Popular Elite Plan](https://www.biopharmcatalyst.com/sign-up?modal=1)

Subscriptions have [Terms & Conditions](https://www.biopharmcatalyst.com/terms-of-use) including but not limited to limited time discounts, trial periods, and lock in clauses. No money charged until free trial is up.

[Already signed up? Login here](https://www.biopharmcatalyst.com/account/login)

We use cookies to analyze traffic and to recognize users who sign in to our premium tools. By using our site, you agree to our use of cookies. For details, read our privacy policy [here](https://www.biopharmcatalyst.com/privacy-policy).

Got It!

[iframe](https://sibautomation.com/cm.html?key=x2p5vl7mghvy2g7ves4ak1s9#cuid=487d2da0-c24d-43ac-adf6-756ab9be4183&cm_flag=true&allow_cookie=&i=0)![](https://rtd-tm.everesttech.net/upi/?sid=0ADi68Fmd6C7a4FJnEx0&cs=1)[iframe](https://js.stripe.com/v3/controller-with-preconnect-7fb49f167d5b99017a414d37f2baef94.html#apiKey=pk_live_51J1HuLK3fngcAWEDcAND5T9CijLnIZz75TWUg8QwUbuHvDeaA3dStOk08MQmivLgwPQ4cZyEyjR6AZoTlOomVI4y00kOAbWlG7&stripeJsId=74aff516-b3f4-4c97-bf3f-b145c9377019&controllerCount=1&isCheckout=false&stripeJsLoadTime=1719932720385&manualBrowserDeprecationRollout=false&alwaysUseMuasForElementsSession=false&mids[guid]=NA&mids[muid]=NA&mids[sid]=NA&referrer=https%3A%2F%2Fwww.biopharmcatalyst.com%2Fcalendars%2Ffda-calendar&controllerId=__privateStripeController9061)[iframe](https://js.stripe.com/v3/m-outer-3437aaddcdf6922d623e172c2d6f9278.html#url=https%3A%2F%2Fwww.biopharmcatalyst.com%2Fcalendars%2Ffda-calendar&title=FDA%20Calendar%20%E2%80%A2%20BioPharmCatalyst&referrer=https%3A%2F%2Fwww.google.com%2F&muid=NA&sid=NA&version=6&preview=false&metaReferrerPolicy=no-referrer-when-downgrade)

[iframe](https://googleads.g.doubleclick.net/pagead/ads?client=ca-pub-2998754655820592&output=html&adk=1812271804&adf=3025194257&abgtt=3&lmt=1719932723&plaf=1%3A2%2C2%3A2%2C7%3A2&plat=1%3A128%2C2%3A128%2C3%3A128%2C4%3A128%2C8%3A128%2C9%3A32776%2C16%3A8388608%2C17%3A32%2C24%3A32%2C25%3A32%2C30%3A1081344%2C32%3A32%2C41%3A32%2C42%3A32&format=0x0&url=https%3A%2F%2Fwww.biopharmcatalyst.com%2Fcalendars%2Ffda-calendar&pra=7&wgl=1&easpi=0&aihb=0&asro=0&ailel=32~30~29~1~2~4~6~7~8~9~10~11~12~13~14~15~16~17~18~19~20~21~24&aiael=32~30~29~1~2~4~6~7~8~9~10~11~12~13~14~15~16~17~18~19~20~21~24&aifxl=32_7~30_23~29_18&aiixl=32_9~30_6~29_5&aslmct=0.7&asamct=0.7&aifgd=1&aipaq=1&aisaib=1&uach=WyJXaW5kb3dzIiwiMTAuMC4wIiwieDg2IiwiIiwiMTI0LjAuNjM2Ny43OCIsbnVsbCwwLG51bGwsIjY0IixbWyJDaHJvbWl1bSIsIjEyNC4wLjYzNjcuNzgiXSxbIkdvb2dsZSBDaHJvbWUiLCIxMjQuMC42MzY3Ljc4Il0sWyJOb3QtQS5CcmFuZCIsIjk5LjAuMC4wIl1dLDBd&dt=1719932722329&bpp=3&bdt=2544&idt=1176&shv=r20240625&mjsv=m202406250101&ptt=9&saldr=aa&abxe=1&cookie_enabled=1&eoidce=1&prev_fmts=500x130&nras=1&correlator=1311049464380&frm=20&pv=1&ga_vid=1178398218.1719932721&ga_sid=1719932723&ga_hid=301851603&ga_fc=1&u_tz=-420&u_his=2&u_h=1080&u_w=1920&u_ah=1080&u_aw=1920&u_cd=16&u_sd=1&dmc=0.001953125&adx=-12245933&ady=-12245933&biw=1919&bih=992&scr_x=0&scr_y=0&eid=44759837%2C42531705%2C42532523%2C44795921%2C95331689%2C95334509%2C95334524%2C95334571%2C95334830%2C95335888%2C95335247&oid=2&pvsid=1594648592966589&tmod=434270934&uas=3&nvt=1&fsapi=1&ref=https%3A%2F%2Fwww.google.com%2F&fc=896&brdim=0%2C0%2C0%2C0%2C1920%2C0%2C1919%2C1079%2C1919%2C992&vis=1&rsz=%7C%7Cs%7C&abl=NS&fu=33792&bc=31&bz=1&psd=W251bGwsbnVsbCxudWxsLDNd&ifi=2&uci=a!2&fsb=1&dtd=1192)

[iframe](https://googleads.g.doubleclick.net/pagead/html/r20240625/r20110914/zrt_lookup_fy2021.html)